薬剤溶出ステント（DES）の世界市場は、2022年に約73億7,000万米ドルと評価され、予測期間の2023年から2030年には6.6%以上の健全な成長率で成長すると予測されています。
薬剤溶出ステントは、冠動脈疾患として知られる動脈の狭窄や閉塞を治療するためのインターベンショナル心臓病学で使用される医療機器です。ステントは通常ステンレス鋼またはコバルトクロム合金製の小さな金属管で、動脈内の瘢痕組織の形成を防ぎ、血流を確保するように設計された特別な薬剤でコーティングされています。薬剤溶出ステント市場は、心血管疾患の有病率の増加や老人人口の増加などの要因により拡大しています。DESの開発は、ベアメタルステントでは一般的な問題であった再狭窄として知られる動脈再狭窄のリスクを低減することで、冠動脈疾患の治療に革命をもたらしました。再狭窄の有病率はここ数十年の間に徐々に増加しています。
米国心臓協会によると、心血管系疾患は依然としてアメリカにおける死因の第1位であり、2020年の死亡者数は928,741人でした。さらに、2020年のアメリカにおけるCVDに起因する死因の第1位は冠動脈性心疾患で約41.2％、次いで脳卒中が17.3％、その他の心血管疾患が16.8％となっています。本市場を推進するもう一つの重要な要素は、高齢者人口の増加です。高齢者や肥満の人々は慢性疾患にかかりやすいためです。世界銀行グループによると、2020年の世界の高齢者人口は7億2,700万人で、今後30年間で3倍に増加し、2050年には15億人に達すると予測されています。さらに、2022年5月には、Biosensors International Groupが BioFreedom Ultra を発売しました。これは、Biosensors社の特許取得済みのリムス治療薬 Biolimus A9 を使用した、新しいポリマーとキャリアフリーの薬剤でコーティングされたステントです。これは、Biosensors社が開発した冠動脈血管用途の高親油性の抗再狭窄薬です。BioFreedom Ultraには、さらに84mの薄いコバルトクロム（Co/Cr）ストラットが含まれています。また、薬剤溶出ステントの製剤化が進み、生分解性ポリマーベースの薬剤溶出スキャフォールドの需要が増加していることも、予測期間中に同市場に有利な成長見通しをもたらすでしょう。しかし、薬剤溶出ステントのコストが高いことが、2023年から2030年の予測期間を通じて市場の成長を阻害するでしょう。
世界の薬剤溶出ステント市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。北アメリカは、主要市場プレイヤーの存在と健康診断機器における技術進歩の高まりにより、2022年の市場を支配しました。Statistaによると、2021年、北アメリカの心臓血管手術件数は202,907件が冠動脈バイパス移植術、258,139件が分離弁手術となっています。アジア太平洋地域は、高齢者人口の増加や政府機関の市場参入などの要因により、予測期間中に大きく成長することが期待されている。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Drug-Eluting Stents Market, by Region, 2020-2030 (USD Billion)
1.2.2. Drug-Eluting Stents Market, by Coating, 2020-2030 (USD Billion)
1.2.3. Drug-Eluting Stents Market, by Application, 2020-2030 (USD Billion)
1.2.4. Drug-Eluting Stents Market, by End-User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Drug-Eluting Stents Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Drug-Eluting Stents Market Dynamics
3.1. Drug-Eluting Stents Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cardiovascular disease
3.1.1.2. Rise in Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost of Drug-Eluting Stents
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation of Drug-Eluting Stents
3.1.3.2. Increasing demand for biodegradable polymer-based drug eluting scaffolds
Chapter 4. Global Drug-Eluting Stents Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Drug-Eluting Stents Market, by Coating
5.1. Market Snapshot
5.2. Global Drug-Eluting Stents Market by Coating, Performance - Potential Analysis
5.3. Global Drug-Eluting Stents Market Estimates & Forecasts by Coating 2020-2030 (USD Billion)
5.4. Drug-Eluting Stents Market, Sub Segment Analysis
5.4.1. Polymer Based
5.4.2. Polymer Free
Chapter 6. Global Drug-Eluting Stents Market, by Application
6.1. Market Snapshot
6.2. Global Drug-Eluting Stents Market by Application, Performance - Potential Analysis
6.3. Global Drug-Eluting Stents Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Drug-Eluting Stents Market, Sub Segment Analysis
6.4.1. Coronary Artery Disease
6.4.2. Peripheral Artery Disease
Chapter 7. Global Drug-Eluting Stents Market, by End-User
7.1. Market Snapshot
7.2. Global Drug-Eluting Stents Market by End-User, Performance - Potential Analysis
7.3. Global Drug-Eluting Stents Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
7.4. Drug-Eluting Stents Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centres
7.4.3. Others
Chapter 8. Global Drug-Eluting Stents Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Drug-Eluting Stents Market, Regional Market Snapshot
8.4. North America Drug-Eluting Stents Market
8.4.1. U.S. Drug-Eluting Stents Market
8.4.1.1. Coating breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Drug-Eluting Stents Market
8.5. Europe Drug-Eluting Stents Market Snapshot
8.5.1. U.K. Drug-Eluting Stents Market
8.5.2. Germany Drug-Eluting Stents Market
8.5.3. France Drug-Eluting Stents Market
8.5.4. Spain Drug-Eluting Stents Market
8.5.5. Italy Drug-Eluting Stents Market
8.5.6. Rest of Europe Drug-Eluting Stents Market
8.6. Asia-Pacific Drug-Eluting Stents Market Snapshot
8.6.1. China Drug-Eluting Stents Market
8.6.2. India Drug-Eluting Stents Market
8.6.3. Japan Drug-Eluting Stents Market
8.6.4. Australia Drug-Eluting Stents Market
8.6.5. South Korea Drug-Eluting Stents Market
8.6.6. Rest of Asia Pacific Drug-Eluting Stents Market
8.7. Latin America Drug-Eluting Stents Market Snapshot
8.7.1. Brazil Drug-Eluting Stents Market
8.7.2. Mexico Drug-Eluting Stents Market
8.8. Middle East & Africa Drug-Eluting Stents Market
8.8.1. Saudi Arabia Drug-Eluting Stents Market
8.8.2. South Africa Drug-Eluting Stents Market
8.8.3. Rest of Middle East & Africa Drug-Eluting Stents Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Boston Scientific Corporation
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Medtronic plc
9.3.3. Abbott Laboratories
9.3.4. Biosensors International Group
9.3.5. AlviMedica Medical Technologies Inc.
9.3.6. Amaranth Medical, Inc.
9.3.7. HangZhou HuaAn Biotechnology Co., Ltd
9.3.8. XTENT, Inc.
9.3.9. Cardionovum GmbH
9.3.10. Kyoto Medical Planning Co., Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global Drug-Eluting Stents Market, report scope
TABLE 2. Global Drug-Eluting Stents Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Drug-Eluting Stents Market estimates & forecasts by Coating 2020-2030 (USD Billion)
TABLE 4. Global Drug-Eluting Stents Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Drug-Eluting Stents Market estimates & forecasts by End-User 2020-2030 (USD Billion)
TABLE 6. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Drug-Eluting Stents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Drug-Eluting Stents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Drug-Eluting Stents Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Drug-Eluting Stents Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Drug-Eluting Stents Market
TABLE 71. List of primary sources, used in the study of global Drug-Eluting Stents Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Drug-Eluting Stents Market, research methodology
FIG 2. Global Drug-Eluting Stents Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Drug-Eluting Stents Market, key trends 2022
FIG 5. Global Drug-Eluting Stents Market, growth prospects 2023-2030
FIG 6. Global Drug-Eluting Stents Market, porters 5 force model
FIG 7. Global Drug-Eluting Stents Market, pest analysis
FIG 8. Global Drug-Eluting Stents Market, value chain analysis
FIG 9. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Drug-Eluting Stents Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Drug-Eluting Stents Market, regional snapshot 2020 & 2030
FIG 15. North America Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 16. Europe Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Drug-Eluting Stents Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
